SCHEMBL7522934

SCHEMBL7522934

O=S1(=O)[N]Cc2cccc3cccc1c23

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.38
TSHR P16473 2/20 0.38
KDM4E B2RXH2 7/20 0.35
ALDH1A1 P00352 6/20 0.35
HPGD P15428 5/20 0.35
POLB P06746 1/20 0.34
HSD17B10 Q99714 4/20 0.33
CYP1A2 P05177 3/20 0.33
CYP2C19 P33261 2/20 0.33
TYMS P04818 1/20 0.33
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
NPC1 O15118 1/20 0.33
PARP1 P09874 1/20 0.33
RAB9A P51151 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
CYP1A1 P04798 1/20 0.31
CYP1B1 Q16678 1/20 0.31
USP2 O75604 1/20 0.31
ALOX15 P16050 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2782984 0.78 CA12 (0.39) TSHRKDM4EALDH1A1CYP1A2MEN1
SCHEMBL13513238 0.71 TSHR (0.41) CYP3A4TSHRKDM4EALDH1A1HPGD
SCHEMBL7524437 0.68 PARP1 (0.44) CYP3A4TSHRKDM4EALDH1A1HPGD
SCHEMBL686577 0.66 TSHR (0.50) CYP3A4TSHRKDM4EALDH1A1HPGD
SCHEMBL11256812 0.64 CA12 (0.35) CYP3A4TSHRKDM4EALDH1A1HPGD
SCHEMBL11841056 0.63 MEN1 (0.58) CYP3A4TSHRKDM4EALDH1A1HPGD
SCHEMBL7523238 0.63 ALDH1A1 (0.42) CYP3A4TSHRKDM4EALDH1A1HPGD
SCHEMBL2763395 0.63 RAB9A (0.37) TSHRKDM4EALDH1A1KMT2ARAB9A
SCHEMBL11384264 0.62 ALDH1A1 (0.41) TSHRKDM4EALDH1A1HPGDHSD17B10
SCHEMBL4628961 0.61 TSHR (0.44) CYP3A4TSHRKDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1090000-A4 NAPHTHO 1,8-DE]THIASIN-2-YL METHYL CARBAPENEM ANTIBACTERIALS MERCK & CO INC (US) 2002-11-27 EP disclosed
US-6346526-B1 CARBAPENICILLIN WITH 1,1-DIOXO-2,3-DIHYDRONAPHTHO(1,8-DE)(1,2)THIAZIN-2-YL-SUBSTITUENT; TREATING STAPHYLOCOCCUS INFECTIONS RESISTANT TO METHICILLIN; SIDE EFFECT REDUCTION MERCK & CO., INC. 2002-02-12 US disclosed
EP-1090000-A1 NAPHTHO 1,8-DE]THIASIN-2-YL METHYL CARBAPENEM ANTIBACTERIALS Merck & Co., Inc. (US) 2001-04-11 EP disclosed
WO-1999067242-A1 NAPHTHO[1,8-DE]THIASIN-2-YL METHYL CARBAPENEM ANTIBACTERIALS MERCK & CO., INC. (US) 1999-12-29 WO disclosed